• Research
  • About
  • Experts
Carnegie India logoCarnegie lettermark logo
AI
{
  "authors": [
    "Mark Hibbs"
  ],
  "type": "other",
  "centerAffiliationAll": "dc",
  "centers": [
    "Carnegie Endowment for International Peace"
  ],
  "collections": [
    "Iranian Proliferation"
  ],
  "englishNewsletterAll": "ctw",
  "nonEnglishNewsletterAll": "",
  "primaryCenter": "Carnegie Endowment for International Peace",
  "programAffiliation": "NPP",
  "programs": [
    "Nuclear Policy"
  ],
  "projects": [],
  "regions": [
    "Middle East",
    "Iran"
  ],
  "topics": [
    "Nuclear Policy"
  ]
}

Source: Getty

Other

Implement the JCPOA

Instead of putting the JCPOA in jeopardy, the United States would be well advised to permit the implementation of the agreement to go forward and, together with other parties, encourage the IAEA to vigorously pursue its obligations under the agreement.

Link Copied
By Mark Hibbs
Published on Oct 5, 2017

Source: Arms Control Wonk

Very shortly, the United States government will make decisions about the Joint Comprehensive Plan of Action (JCPOA) that may have immediate and profound implications for Iran and the U.S; for the future of the Middle East; and for global efforts to prevent the spread of nuclear arms.

The JCPOA ultimately rests upon the authority of the International Atomic Energy Agency (IAEA) to verify that all of Iran’s nuclear activities are declared and peaceful. Without the agreement, IAEA verification would be far more difficult. This should dissuade President Trump and the Congress from taking reckless actions that could curtail the IAEA’s fact-finding, preempt American credibility in dealing with Iran in the future, and terminate enhanced oversight in a country that could respond by ramping up its nuclear program to a crisis level.

The unending polarized debate in the U.S. about the JCPOA has allowed both defenders and detractors to misrepresent the facts concerning the implementation of the accord. In their zeal to burnish the JCPOA, advocates assert that the IAEA has concluded that Iran is complying with the agreement. That’s overstated, as are woefully gratuitous claims by declared opponents of the JCPOA that Iran is hiding current non-compliance because the Obama Administration “gave away any right to conduct meaningful inspections in Iran.”

This article was originally published in Arms Control Wonk.

Read the article

About the Author

Mark Hibbs

Nonresident Senior Fellow, Nuclear Policy Program

Hibbs is a Germany-based nonresident senior fellow in Carnegie’s Nuclear Policy Program. His areas of expertise are nuclear verification and safeguards, multilateral nuclear trade policy, international nuclear cooperation, and nonproliferation arrangements.

    Recent Work

  • Article
    Dimming Prospects for U.S.-Russia Nonproliferation Cooperation
      • Nicole Grajewski Profile Picture
      • +1

      Toby Dalton, Mark Hibbs, Nicole Grajewski, …

  • Commentary
    What Comes After Russia’s Attack on a Ukrainian Nuclear Power Station?

      Mark Hibbs

Mark Hibbs
Nonresident Senior Fellow, Nuclear Policy Program
Mark Hibbs
Nuclear PolicyMiddle EastIran

Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.

More Work from Carnegie India

  • Article
    Risk and Retaliation: Israel, Iran, and the Evolving Situation in West Asia

    An Israeli response to Iran’s October 1 attack is imminent. The key question is of its intensity and potential fallout, both within Iran, in terms of nuclear security policy changes, and across the broader region. The coming days are likely to reshape West Asia irreversibly.

      Gaddam Dharmendra

  • Commentary
    How WHO’s “One Health” Program Can Help India Tackle Monkeypox

    With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.

      Shruti Sharma

  • Paper
    Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India

    In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.

      Shruti Sharma

  • Commentary
    Combating Vaccine Hesitancy in India

    Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.

      Shruti Sharma

  • Commentary
    How Should Countries Study Viruses Safely?

    The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?

      Shruti Sharma

Get more news and analysis from
Carnegie India
Carnegie India logo, white
Unit C-4, 5, 6, EdenparkShaheed Jeet Singh MargNew Delhi – 110016, IndiaPhone: 011-40078687
  • Research
  • About
  • Experts
  • Projects
  • Events
  • Contact
  • Careers
  • Privacy
  • For Media
Get more news and analysis from
Carnegie India
© 2026 Carnegie Endowment for International Peace. All rights reserved.